E-sports era

CJ Bioscience to Present Preclinical Data on Inflammatory Bowel Disease Pipeline Candidate CJRB-201 at 'ECCO 2025'; Clinical Entry Targeted for 2026

\'CJRB-201\',a proprietary strain of Faecalibacterium with potent its anti-inflammatory effects,has demonstrated the strongest induction of regulatory T cells (Tregs) among analyzed strains.

02-19 CJ Bioscience

GoDaddy Airo®: An AI-Powered Revolutionary Solution for Pakistani Entrepreneurs and Small Business Owners

GoDaddy Airo Delivers website creation,logo design and digital marketing strategies for entrepreneurs to get started online quickly

02-19 GoDaddy

PharmaBlock Launches Commercial GMP Workshop 503 at Zhejiang Site

NANJING,China,Feb. 18,2025-- PharmaBlock Sciences (Nanjing),Inc. (Stock code: 300725.SZSE) has announced the official launch of its commercial GMP Workshop 503 (W503) at PharmaBlock Zhejiang. The new

02-19 PharmaBlock

Stryker launches ProCeed hospital bed

New hospital bed helps caregivers deliver efficient and quality care in markets outside the U.S. PORTAGE,Mich.,Feb. 17,2025-- Stryker (NYSE:SYK),a global leader in medical technologies,announced the

02-18

TAHO Pharmaceuticals Reports Positive Results from Pivotal Study of TAH3311, the First Oral Dissolving Film Anticoagulant

TAIPEI,Feb. 17,2025-- TAHO Pharmaceuticals announces positive preliminary results from the pivotal study of TAH3311,the world\'s first Apixaban oral dissolving film (ODF). The study confirmed that TAH

02-18

Minish Holds First Seminar in Japan with Great Success - Over 100 Dentists in Attendance

"Impressed by Extensive Full-Mouth Rehabilitation Cases","Anti-Aging Effects Highly Praised"

02-18 Minish Technology Inc.

Reolink Makes Wireless Security Camera Systems Accessible to All Homes

LOS ANGELES,Feb. 17,2025-- Every homeowner deserves peace of mind when it comes to home security. Reolink,an innovative leader in intelligent visual technology for the home,brings the Wireless Securi

02-18 Reolink Innovation Inc.

Duke and Duke-NUS forge new frontiers in climate health research with S$1million funding

The two institutions awarded more than S$1 million to accelerate five promising areas of research collaboration

02-17

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Ovarian Cancer of Anti-HER2 Bispecific ADC JSKN003

SUZHOU,China,Feb. 13,2025-- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-306) of anti-HER2 bi

02-14

DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development

SEOUL,South Korea,Feb. 13,2025-- DAAN Biotherapeutics,a leading innovative drug development company specializing in T-cell receptor (TCR)- based therapies,has signed an exclusive licensing agreement w

02-14